For millions of people, the conclude of an acute COVID-19 infection did not mark a return to full health, but the beginning of a complex, lingering struggle. New data suggests that for those navigating this aftermath, the danger extends beyond fatigue and cognitive fog. A significant population-based study indicates that long COVID and risk of incident cardiovascular disease are closely linked, with patients facing a heightened probability of developing heart-related conditions even if their initial infection was mild to moderate.
The research, conducted using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohort, tracked over 1.2 million residents in Stockholm County. The findings reveal that individuals with a physician-assigned long COVID diagnosis experienced a markedly higher incidence of major cardiovascular events compared to those without the condition. This suggests that the virus’s impact on the body is not limited to the respiratory system, but can leave a lasting footprint on the heart and vascular network.
Crucially, the study highlighted that this increased risk persists even among patients who were never hospitalized during their acute illness. This challenges the notion that only severe cases of COVID-19 lead to long-term organ damage, suggesting instead that the systemic inflammatory response or vascular changes associated with the virus can trigger cardiovascular issues in a broader segment of the population.
The trend is not evenly distributed across genders. While both men and women showed increased risks, women with long COVID faced a significantly higher relative risk of receiving a cardiovascular diagnosis—just over twice the risk of women without long COVID—compared to men, who saw approximately a third higher risk.
The Cardiovascular Burden: Breaking Down the Risks
The MIRACLE-S cohort study, published in eClinicalMedicine, analyzed data from October 2020 through January 2025. Researchers found that the cumulative incidence of any cardiovascular event was substantially higher in the long COVID group: 18.2% of women and 20.6% of men experienced an event, compared to 8.4% of women and 11.1% of men in the control group.
The most striking disparity appeared in the risk of cardiac arrhythmias. For women with long COVID, the hazard ratio (HR) for arrhythmias was 3.11, meaning they were more than three times as likely to develop the condition. Men also faced an elevated risk, with an HR of 1.61. Coronary artery disease also showed an increase across both sexes, with hazard ratios of 1.25 for women and 1.26 for men.
Certain conditions appeared to affect women exclusively within this cohort. The study found an elevated incidence of heart failure (HR 1.25) and peripheral artery disease (HR 1.25) specifically in women with long COVID. Interestingly, the researchers found that long COVID was not associated with an increased risk of stroke in either sex.
| Condition | Risk (Women) | Risk (Men) |
|---|---|---|
| Composite CV Outcome | HR 2.06 | HR 1.33 |
| Cardiac Arrhythmia | HR 3.11 | HR 1.61 |
| Coronary Artery Disease | HR 1.25 | HR 1.26 |
| Heart Failure | HR 1.25 | Not Significant |
| Peripheral Artery Disease | HR 1.25 | Not Significant |
A Pattern of Cardiac Instability Since 2020
The connection between SARS-CoV-2 and heart dysfunction was evident from the earliest days of the pandemic. In April 2020, the New York City Fire Department reported a 400% increase in sudden cardiac arrest deaths. This surge was so abrupt that the city implemented new standards of care for CPR and cardiac arrest in the field to manage the crisis.
Shortly thereafter, a JAMA investigation documented a 10-fold increase in out-of-hospital cardiac arrests in New York City during the peak of the epidemic. These early signals indicated that the virus was not merely a respiratory ailment but a systemic threat capable of causing blood clots and severe cardiovascular damage.
By the summer of 2020, medical literature began to warn of a “next chapter” in the pandemic: the potential for a wave of heart failure cases. As the pandemic progressed, the focus shifted toward post-acute sequelae, with evidence mounting that repeated infections could compound long-term health damage. This trajectory suggests that the cardiovascular risks associated with long COVID are part of a larger, ongoing public health challenge that extends far beyond the initial infection window.
The Gap Between Clinical Data and Public Perception
Despite the volume of evidence linking COVID-19 to cardiovascular morbidity, there is a growing disconnect between clinical findings and public perception. As the acute phase of the pandemic faded, many began to view the virus as no more severe than a common cold. This shift in perception has coincided with a decline in vaccine uptake, as some erroneously believe the risk of vaccination outweighs the risk of the virus itself.
However, recent research continues to emphasize the dangers of the infection. A study published in PLoS Medicine found no evidence that COVID-19 vaccines increase the risk of sudden cardiac death in young, healthy adults. Conversely, the study identified a strong link between recent COVID-19 infection and an increased risk of sudden cardiac death.
For patients, this means that the “mild” label often applied to a primary infection can be misleading. The MIRACLE-S data underscores that the burden of cardiovascular morbidity remains high even for those who did not require intensive hospital care during their acute illness. The medical community is now calling for the integration of long COVID history into standard cardiovascular risk assessments to ensure that at-risk patients receive the necessary monitoring and preventative care.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare provider for medical diagnosis and treatment.
As researchers continue to analyze the long-term effects of the pandemic, the next critical checkpoint will be the development of standardized clinical guidelines for the systematic follow-up of long COVID patients. These protocols aim to integrate cardiovascular screening into primary care for those with a history of the virus to catch arrhythmias and heart failure in their earliest stages.
We invite you to share your experiences or questions in the comments below and share this article with others who may be navigating long-term recovery.
